{
    "clinical_study": {
        "@rank": "152901", 
        "arm_group": [
            {
                "arm_group_label": "ACZ885", 
                "arm_group_type": "Experimental", 
                "description": "1 mL ACZ885 given as a subcutaneous injection"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "1 mL placebo given as a subcutaneous injection"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is designed to assess the safety, tolerability and efficacy of ACZ885 on the leg\n      artery structure and physical activity in patients with atherosclerotic peripheral artery\n      disease and leg pain from walking."
        }, 
        "brief_title": "Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Peripheral Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Intermittent Claudication", 
                "Peripheral Arterial Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must have a signed informed consent form.\n\n          -  Must be between the ages of 18 and 80\n\n          -  Must experience leg pain associated with walking when walking less than 400 meters\n             and have an ankle brachial index between 0.50 and 0.85\n\n          -  Must be on stable asprin and statin doses for at least  6 weeks\n\n          -  Blood pressure within ranges specificed in the protocol\n\n          -  Able to communicate well with the Investigator and understand and comply with the\n             study procedures\n\n        Exclusion Criteria:\n\n          -  Recent use of any other experimental drugs\n\n          -  Pregnant or nursing women\n\n          -  Women of child bearing potential unless willing to use contraception as detailed in\n             the protocol\n\n          -  Cannot walk 50 meters\n\n          -  People on restricted medications as listed in the protocol\n\n          -  Any open or non-healing wounds with 3 months of study start or infection within 2\n             weeks or study start\n\n          -  Significant heart disease\n\n          -  Uncontrolled diabetes\n\n          -  Significant kidney or liver disease\n\n          -  Live vaccinations with 3 months of study start\n\n          -  History of untreated tuberculosis or active tuberculosis (TB)\n\n          -  Patients with metal in their body (excluded due to MRI scan) as detailed in the\n             protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01731990", 
            "org_study_id": "CACZ885M2201", 
            "secondary_id": "2012-001427-12"
        }, 
        "intervention": [
            {
                "arm_group_label": "ACZ885", 
                "intervention_name": "ACZ885", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Matching placebo of CACZ88%M", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Peripheral artery disease", 
            "Intermittent claudication", 
            "magnetic resonance imaging"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Glendale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85301"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fleming Island", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32003"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32207"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32216"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Orange", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32127"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "606011"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43215"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45439"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37920"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23294"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20099"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "22559"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlsbad", 
                        "country": "Germany", 
                        "zip": "76307"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mainz", 
                        "country": "Germany", 
                        "zip": "55116"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amman", 
                        "country": "Jordan", 
                        "zip": "11941"
                    }, 
                    "name": "Novartis Investigative Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Germany", 
                "Jordan"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "1-888-669-6682"
        }, 
        "overall_contact_backup": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone_ext": "+41613241111"
        }, 
        "overall_official": {
            "affiliation": "Novartis Pharmaceuticals", 
            "last_name": "Novartis Pharmaceuticals", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Jordan: Jordan Food and Drug Administration", 
                "Germany: Paul-Ehrlich-Institut", 
                "Israel: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Peripheral artery wall area (superficial femoral artery) measured using MRI cross-section slices. Mean vessel wall volume is the average, for each MRI, over the individual slices of cross- sectional area of the vessel wall measured.", 
            "measure": "Mean vessel wall volume", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01731990"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Summary statistics on adverse event will be reported. It will be categorized as total adverse events, serious adverse event, death.", 
                "measure": "Number of patients with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "baseline to 12 months post-dose"
            }, 
            {
                "measure": "Change from baseline in Serum amyloid A (SAA) level at 12 months post dose", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 12 months post-dose"
            }, 
            {
                "measure": "Change from baseline in high sensitivity C-reactive protein (hsCRP) at 12 month post-dose", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 12 months post-dose"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}